Sign up to save your podcasts
Or
Share ARCHWAY at AAO
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
ARCHWAY at AAO
The Port Delivery System With Ranibizumab (Genentech) is under investigation for the treatment of wet AMD in the phase 3 ARCHWAY trial, data from which was shared at this year’s AAO Annual Meeting. Nancy Holekamp, MD, sits down with NRR to provide a primary analysis of the results of ARCHWAY and discusses safety outcomes.
This editorially independent podcast is supported with advertising.
View all episodes
By Retina Today
4.4
1717 ratings
The Port Delivery System With Ranibizumab (Genentech) is under investigation for the treatment of wet AMD in the phase 3 ARCHWAY trial, data from which was shared at this year’s AAO Annual Meeting. Nancy Holekamp, MD, sits down with NRR to provide a primary analysis of the results of ARCHWAY and discusses safety outcomes.
This editorially independent podcast is supported with advertising.
More shows like New Retina Radio by Eyetube
View all
OIS Podcast | Ophthalmology's leading Podcast
32 Listeners
Ophthalmology off the Grid by Eyetube
44 Listeners
Straight From The Cutter's Mouth: A Retina Podcast
99 Listeners
JAMA Ophthalmology Author Interviews
5 Listeners
The Retina Channel Podcast
11 Listeners
Retina Synthesis
8 Listeners
Headlight in the fog: The Uveitis Podcast
20 Listeners
Experts InSight
48 Listeners
RETINA Journal Podcasts
10 Listeners
Talking Euretina
1 Listeners
Ophthalmology Journal
17 Listeners
Mayo Clinic Ophthalmology Podcast
16 Listeners
ASRS's History of Retina
0 Listeners
ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum
0 Listeners
RetinaRounds™
0 Listeners